Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Army
McKesson
Cerilliant
Mallinckrodt
Healthtrust
Argus Health
Citi
Boehringer Ingelheim
Cipla

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Hypocholesteremic fermentation products and process of preparation
Abstract:Substances isolated after cultivation of a microorganism belonging to the genus Aspergillus in a culture medium comprise compounds which have structures: ##STR1## Together with salts and esters of the carboxylic acid, these compounds form a class of highly active hypocholesteremic and hypolipemic medicaments.
Inventor(s): Albers-Schonberg; George (Princeton, NJ), Joshua; Henry (Staten Island, NY), Lopez; Maria B. (Elizabeth, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Filing Date:May 28, 1981
Application Number:06/267,972
Claims:1. The compound: ##STR6## in substantially pure form or a pharmaceutically acceptable salt or a lower alkyl ester or a substituted lower alkyl ester wherein the substituent is phenyl, dimethylamino, or acetylamino.

2. The pharmaceutically acceptable salts of the compound of claim 1, wherein the cation is derived from ammonia, ethylenediamine, N-methylglucamine, lysine, arginine or ornithine.

3. The ammonium salt of Compound II of claim 1.

4. The ethylenediamine salt of Compound II of claim 1.

5. The lower alkyl esters and substituted lower alkyl esters of the compounds of claim 1.

6. The ethyl ester of Compound II of claim 1.

7. An antihypercholesterolemic pharmaceutical composition comprising a pharmaceutical carrier and an effective antihypercholesterolemic amount of the compound: ##STR7## in substantially pure form or a pharmaceutically acceptable salt or a lower alkyl ester or a substituted lower alkyl ester wherein the substituent is phenyl, dimethylamino, or acetylamino.

8. The composition of claim 7 wherein the compound is a pharmaceuticaly acceptable salt wherein the cation is derived from ammonia, ethylenediamine, N-methylglucamine, lysine, arginine or ornithine.

9. The composition of claim 7 wherein the compound is the ammonium salt of Compound II.

10. The composition of claim 7 wherein the compound is the ethylenediamine salt of Compound II.

11. The composition of claim 7 wherein the compound is a lower alkyl ester or substituted lower alkyl ester.

12. The composition of claim 7 wherein the compound is the ethyl ester of Compound II.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Healthtrust
US Army
UBS
Colorcon
US Department of Justice
Federal Trade Commission
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot